Tianjin Tianyao Pharmaceuticals Co., Ltd. (600488.SS)
CNY 4.5
(-0.66%)
CNY 4.5
(-0.66%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 783 Million | 653.52 Million | 316.88 Million | 346.88 Million | 279.36 Million | 189.26 Million |
| Net Income | 117.05 Million | 18.43 Million | 108.66 Million | 80.57 Million | 183.21 Million | 196.96 Million |
| Depreciation & Amortization | 272.9 Million | 257.07 Million | 208.79 Million | 183.74 Million | 142.81 Million | 108.92 Million |
| Deferred income taxes | -1.11 Million | -8.02 Million | 1.72 Million | 3.51 Million | -2.95 Million | -4.67 Million |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 320.85 Million | 236.91 Million | -47.67 Million | -7.79 Million | -135.3 Million | -201.86 Million |
| Other non-cash items | 350.47 Million | 141.1 Million | 47.09 Million | 90.35 Million | 88.64 Million | 85.24 Million |
| Investing Cash Flow | -132.12 Million | -198.13 Million | -376.95 Million | -584.14 Million | -278.07 Million | -629.65 Million |
| Investments in PPE | -133.14 Million | -202.19 Million | -370.84 Million | -458.51 Million | -279.04 Million | -203.58 Million |
| Acquisitions | 1.02 Million | 4.06 Million | -10.16 Million | -140.02 Million | 73.25 Thousand | -434.76 Million |
| Investment purchases | - | - | 0.70 | - | -73.25 Thousand | 203.58 Million |
| Sales/Maturities of investments | - | - | 3.37 Million | - | 890.95 Thousand | 8.69 Million |
| Other Investing Activities | 1.02 Million | 1.00 | 683.98 Thousand | 14.39 Million | 73.25 Thousand | -203.58 Million |
| Financing Cash Flow | -564.84 Million | -54.57 Million | 92.69 Million | 174.37 Million | -111.13 Million | 303.87 Million |
| Debt repayment | -492.06 Million | -1.15 Billion | -1.2 Billion | -1.94 Billion | -504.81 Million | -402.36 Million |
| Dividends payments | -10.88 Million | -15.31 Million | -11 Million | -43.67 Million | -71.34 Million | -70.93 Million |
| Common Stock Repurchased | -5.77 Million | -8.68 Million | -1.73 Million | -999.08 | - | - |
| Common Stock Issuance | 280.00 | 8.68 Million | 1.73 Million | 999.08 | - | - |
| Other Financing Activities | -56.11 Million | 1.16 Billion | 1.35 Billion | 2.2 Billion | 508.8 Million | 777.16 Million |
| Accounts receivables | -163.08 Million | 87.74 Million | -210.34 Million | -257.55 Million | -119.87 Million | -2.52 Million |
| Accounts payables | 1.00 | -87.74 Million | 210.34 Million | 257.55 Million | 119.87 Million | 367.32 Million |
| Inventory | 431.72 Million | -194.44 Million | 126.06 Million | 216.03 Million | 268.66 Million | -568.32 Million |
| Other working capital | 52.21 Million | 431.35 Million | -173.74 Million | -223.83 Million | -403.96 Million | 366.46 Million |
| Cash at beginning of period | 647.74 Million | 207.39 Million | 173.44 Million | 238.75 Million | 338.82 Million | 479.5 Million |
| Cash at end of period | 718.85 Million | 608.8 Million | 207.39 Million | 173.44 Million | 233.33 Million | 335.18 Million |
| Capital Expenditure | -133.14 Million | -202.19 Million | -370.84 Million | -458.51 Million | -279.04 Million | -203.58 Million |
| Effect of forex changes on cash | 8.16 Million | 589.8 Thousand | 1.32 Million | -2.42 Million | 4.35 Million | -7.8 Million |
| Net cash flow / Change in cash | 71.11 Million | 401.4 Million | 33.95 Million | -65.31 Million | -105.49 Million | -144.32 Million |
| Free Cash Flow | 649.86 Million | 451.32 Million | -53.95 Million | -111.62 Million | 324.9 Thousand | -14.31 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 44.67 Million | 84 Million | 58.01 Million | 117.05 Million | -34.69 Million | 28.34 Million |
| Depreciation & Amortization | - | 71.4 Million | 71.4 Million | 272.9 Million | 69.27 Million | -125.8 Million |
| Deferred income taxes | - | - | - | -1.11 Million | - | 71.84 Million |
| Stock-based compensation | - | - | - | - | - | 253.95 Thousand |
| Change in working capital | - | -52.63 Million | - | 320.85 Million | 268.64 Million | 53.69 Million |
| Other non-cash items | 93.84 Million | 251.67 Million | -6.46 Million | 350.47 Million | 283.03 Million | 123.28 Million |
| Investing Cash Flow | -13.24 Million | -12.95 Million | -24.52 Million | -132.12 Million | -42.17 Million | -40.99 Million |
| Investments in PPE | -13.65 Million | -13.03 Million | -24.12 Million | -133.14 Million | -43.17 Million | -41.02 Million |
| Acquisitions | 415.11 Thousand | 85.83 Thousand | - | 1.02 Million | 1 Million | 26.1 Thousand |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | 415.11 Thousand | 85.83 Thousand | -400 Thousand | 1.02 Million | 1 Million | 26.1 Thousand |
| Financing Cash Flow | -42.22 Million | -262.65 Million | -37.85 Million | -564.84 Million | -24.56 Million | -214.15 Million |
| Debt repayment | -10.5 Million | -160.58 Million | -29.5 Million | -492.06 Million | -78.5 Million | -264.14 Million |
| Dividends payments | -47.93 Million | -102.02 Million | -8.33 Million | -10.88 Million | -3.81 Million | -15.01 Million |
| Common Stock Repurchased | - | - | - | -5.77 Million | -5.77 Million | 5.77 Million |
| Common Stock Issuance | - | - | - | 280.00 | -7.07 Million | -5.77 Million |
| Other Financing Activities | -4.8 Million | -42.58 Thousand | -28.4 Thousand | -56.11 Million | 63.52 Million | 65 Million |
| Accounts receivables | - | -5.13 Million | - | -163.08 Million | -163.08 Million | 206.3 Million |
| Accounts payables | - | - | - | 1.00 | - | - |
| Inventory | - | -47.5 Million | - | 431.72 Million | 431.72 Million | -152.6 Million |
| Other working capital | - | - | - | 52.21 Million | - | - |
| Cash at beginning of period | 692.52 Million | 698.28 Million | 703 Million | 647.74 Million | 455.31 Million | 536.64 Million |
| Cash at end of period | 776.71 Million | 692.52 Million | 698.28 Million | 718.85 Million | 718.85 Million | 438.43 Million |
| Capital Expenditure | -13.65 Million | -13.03 Million | -24.12 Million | -133.14 Million | -43.17 Million | -41.02 Million |
| Effect of forex changes on cash | 1.14 Million | 5.56 Million | 6.11 Million | 8.16 Million | 13.69 Million | 5.31 Million |
| Net cash flow / Change in cash | 84.18 Million | -5.75 Million | -4.72 Million | 71.11 Million | 263.54 Million | -98.21 Million |
| Free Cash Flow | 124.86 Million | 251.24 Million | 27.42 Million | 649.86 Million | 274.44 Million | 110.6 Million |
LINK
CEVA
7725
HSDT
CPHC
9595